Effects of US7 and UL56 on Cell-to-Cell Spread of Human Herpes Simplex Virus 1.

Human herpes simplex virus (HSV), a double-stranded DNA virus belonging to the family and alpha herpesvirus subfamily, is one of the most epidemic pathogens in the population. Cell-to-cell spread is a special intercellular transmission mechanism of HSV that indicates the virulence of this virus. Through numerous studies on mutant HSV strains, many viral and host proteins involved in this process have been identified; however, the mechanisms remain poorly understood.

Antitumor efficacy of CRISPR/Cas9-engineered ICP6 mutant herpes simplex viruses in a mouse xenograft model for lung adenocarcinoma.

Oncolytic viruses (OVs), including oncolytic herpes simplex viruses (oHSVs), are promising therapeutics against cancer. Here, we report two ICP6-mutated HSVs (type I) generated by CRISPR/Cas9, rHSV1/∆RR (with ICP6 ribonucleotide reductase [RR] domain deleted) and rHSV1/∆ICP6 (with a complete deletion of ICP6), exhibiting potent antitumor efficacy against lung adenocarcinoma. Both the mutants showed strong cytotoxicity in vitro, comparable with the control viruses expressing intact ICP6, but in relatively lower titers.

Structural characterization and antiviral activity of two fucoidans from the brown algae Sargassum henslowianum.

Purified fucoidans SHAP-1 and SHAP-2 with apparent molecular weights of 6.55 × 10 and 5.89 × 10, respectively, were isolated from Sargassum henslowianum by ion-exchange and gel-filtration column chromatography.